Gu Lian, Zou Yunling, Huang Yue, Liu Qiang, Chen Han, Chen Jue
Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 600 South Wanping Road, Shanghai, China.
Shanghai Changning Mental Health Center, Shanghai, China.
J Eat Disord. 2021 Sep 15;9(1):114. doi: 10.1186/s40337-021-00469-7.
The high cost of treatment for anorexia nervosa (AN) and lack of trained specialists have resulted in limited accessibility of effective treatment to patients with AN, which is particularly problematic in China. To increase the accessibility of evidence-based treatment and reduce the cost of treatment, this study aimed to explore the feasibility and efficacy of group cognitive behavior therapy (G-CBT) adapted from enhanced cognitive behavior therapy for eating disorders (CBT-E) in Chinese AN patients.
A total of 78 patients with AN were assigned to G-CBT or individual outpatient treatment (IOT) and received three months of treatment for AN in each condition. Measures of eating pathology, depression and anxiety were administrated to both intervention groups at three time points: baseline, one month of treatment, and end of treatment; results were compared between groups and over time.
There were 70 participants included in the final analysis. Both G-CBT and IOT groups showed significant improvement in eating pathology and associated psychopathology (ps < .001) over the course of treatment, but no significant difference in symptom improvement was found between the two groups (ps > .05). G-CBT resulted in additional significant improvement in ED psychopathology over the last two months of treatment, and its overall therapeutic effect was influenced by baseline weight and early symptom improvement.
Preliminary findings from this open label trial suggest that G-CBT adapted from CBT-E is feasible in an outpatient setting and as effective as IOT in facilitating weight regain and reducing psychopathology in Chinese AN patients with little evidence for the superiority of either intervention.
The current study was registered at clinical trials.gov on September 23, 2018 (registration number NCT03684239). People with anorexia nervosa (AN) are known to be unmotivated for treatment and prone to relapse. Recovery from AN often needs intensive, long-term treatment from a specialized multidisciplinary team, which is not accessible for most people in China. Given the increasing incidence of AN and lack of eating disorder (ED) specialists in China, it is important to develop short-term cost-effective treatments for AN. In this study, we explored the feasibility and efficacy of group cognitive behavior therapy (G-CBT) adapted from enhanced cognitive behavior therapy (CBT-E) for people with AN from China. We found that G-CBT was as effective as individual outpatient treatment (IOT) typically provided to AN patients at the research site in facilitating weight regain, improving eating behaviors, and reducing ED and other symptoms. We also found that patients receiving G-CBT made more improvements in cognitive symptoms of the ED, which might help maintain treatment gains and prevent relapse in the long run. This potential long-term advantage of G-CBT needs to be verified in long-term follow-up.
神经性厌食症(AN)的治疗费用高昂且缺乏训练有素的专家,这导致AN患者难以获得有效的治疗,在中国这一问题尤为突出。为了提高循证治疗的可及性并降低治疗成本,本研究旨在探讨改编自强化饮食失调认知行为疗法(CBT-E)的团体认知行为疗法(G-CBT)在中国AN患者中的可行性和疗效。
总共78例AN患者被分配至G-CBT组或个体门诊治疗(IOT)组,并在每种治疗条件下接受为期三个月的AN治疗。在三个时间点对两个干预组进行饮食病理学、抑郁和焦虑测量:基线、治疗一个月时和治疗结束时;对组间结果和不同时间的结果进行比较。
最终分析纳入70名参与者。在治疗过程中,G-CBT组和IOT组在饮食病理学及相关精神病理学方面均有显著改善(p<0.001),但两组间症状改善无显著差异(p>0.05)。G-CBT在治疗的最后两个月导致饮食失调精神病理学方面有额外的显著改善,其总体治疗效果受基线体重和早期症状改善的影响。
这项开放标签试验的初步结果表明,改编自CBT-E的G-CBT在门诊环境中是可行的,并且在促进中国AN患者体重恢复和减少精神病理学方面与IOT一样有效,几乎没有证据表明两种干预措施哪一种更具优势。
本研究于2018年9月23日在clinicaltrials.gov注册(注册号NCT03684239)。已知神经性厌食症(AN)患者缺乏治疗动力且容易复发。从AN中康复通常需要专业多学科团队进行强化、长期的治疗,而这在中国大多数人无法获得。鉴于中国AN发病率的上升以及饮食失调(ED)专家的缺乏,开发针对AN的短期成本效益高的治疗方法很重要。在本研究中,我们探讨了改编自强化认知行为疗法(CBT-E)的团体认知行为疗法(G-CBT)对中国AN患者的可行性和疗效。我们发现,G-CBT在促进体重恢复、改善饮食行为以及减少ED和其他症状方面与研究地点通常为AN患者提供的个体门诊治疗(IOT)一样有效。我们还发现,接受G-CBT的患者在ED的认知症状方面有更多改善,这可能有助于长期维持治疗效果并预防复发。G-CBT的这种潜在长期优势需要在长期随访中得到验证。